The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of alternating mXELOX/mXELIRI plus bevacizumab (BEV) as first-line treatment for metastatic colorectal cancer (mCRC).
 
Sheng Li
No Relationships to Disclose
 
Liangjun Zhu
No Relationships to Disclose
 
Xiaoyou Li
No Relationships to Disclose
 
Jiayuan Huang
No Relationships to Disclose
 
Hanfeng Xu
No Relationships to Disclose